Boris Labar
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Geriatrics and Gerontology top 10%
- Frailty in Older Adults
Papers in
-
- Acute Myeloid Leukemia Research 3
- Multiple Myeloma Research and Treatments 2
- Chronic Myeloid Leukemia Treatments 1
- Hematopoietic Stem Cell Transplantation 1
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Barbara Deschler-Baier (1 shared paper)Helmut Rainer Salih (1 shared paper)P. W. Wijermans (1 shared paper)Peter S. Haas (1 shared paper)T. de Witte (2 shared papers)Roel Willemze (4 shared papers)Ulrich Germing (1 shared paper)Stefan Suciu (4 shared papers)
- Journals
- Haematologica (3 papers)British Journal of Haematology (1 paper)Leukemia Research (1 paper)The Lancet (1 paper)Bulletin of Environmental Contamination and Toxicology (1 paper)
- Partner nations
- CroatiaNetherlandsBelgium
In The Last Decade
Boris Labar
12 papers receiving 393 citations
Peers
Comparison fields: 5 of 47
- Hematology 288
- Geriatrics and Gerontology 32
- Public Health, Environmental and Occupational Health 104
- Genetics 38
- Oncology 80
Countries citing papers authored by Boris Labar
This map shows the geographic impact of Boris Labar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Labar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Labar more than expected).
Fields of papers citing papers by Boris Labar
This network shows the impact of papers produced by Boris Labar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Labar. The network helps show where Boris Labar may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Labar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 167 | |
| 2 | A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893). | 1997 | 74 |
| 3 | 1998 | 74 | |
| 4 | 2010 | 52 | |
| 5 | 2010 | 15 | |
| 6 | 2014 | 11 | |
| 7 | 2007 | 4 | |
| 8 | Myeloma kidney: pathogenesis and treatment. | 2001 | 3 |
| 9 | Effect of opioid peptide methionine-enkephalin in long-term cultures of human bone marrow. | 2000 | 2 |
| 10 | 1992 | 2 | |
| 11 | 2015 | 2 | |
| 12 | 1998 | 1 | |
| 13 | ATG for pure red cell aplasia : case series | 2007 | 0 |
| 14 | 2017 | 0 |
About Boris Labar
Boris Labar is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Cancer Research, Pediatrics, Perinatology and Child Health and Internal Medicine, having authored 14 papers that have together received 407 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Acute Myeloid Leukemia Research (3 papers), Erythrocyte Function and Pathophysiology (2 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer Genomics and Diagnostics (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and Carcinogens and Genotoxicity Assessment (1 paper). The work is most often cited by research in Hematology (288 citations), Geriatrics and Gerontology (32 citations), Public Health, Environmental and Occupational Health (104 citations), Genetics (38 citations) and Oncology (80 citations). Boris Labar has collaborated with scholars based in Croatia, Netherlands and Belgium. Frequent co-authors include Barbara Deschler-Baier, Helmut Rainer Salih, P. W. Wijermans, Peter S. Haas, T. de Witte, Roel Willemze, Ulrich Germing, Stefan Suciu, Kurt Fritzsche and Gabriele Ihorst. Their work appears in journals such as Haematologica, British Journal of Haematology, Leukemia Research, The Lancet and Bulletin of Environmental Contamination and Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.